Core Viewpoint - The article discusses a study revealing that the ketogenic diet (KD) alleviates septic lung injury through the microbial gut-lung axis, highlighting its potential therapeutic benefits in sepsis management [4][10]. Group 1: Study Findings - The ketogenic diet modifies gut microbiota in both mice and humans, enriching specific strains such as Limosilactobacillus reuteri and Lactiplantibacillus plantarum [6]. - These gut bacteria produce a flavin-dependent monooxygenase that converts oleic acid from the ketogenic diet into azelaic acid, which migrates to the lungs during sepsis [6]. - Azelaic acid enhances the efferocytosis process by activating PPAR-γ, promoting the apoptosis of neutrophils and the expansion of MerTK+ alveolar macrophages, thereby aiding in lung injury recovery [6][9]. Group 2: Clinical Implications - Elevated levels of azelaic acid in septic patients correlate with improved clinical outcomes, including increased survival rates, reduced days on mechanical ventilation, and enhanced lung function [6][9]. - The findings underscore the interaction between diet and gut microbiota in mediating gut-lung communication pathways, emphasizing the therapeutic potential of the ketogenic diet and microbiota modulation in sepsis [10].